Due to estrogen deficiency in postmenopausal women, the expression of insulin receptor and insulin receptor substrate-1/2 (IRS-1/2) is reduced, and the insulin signal transduction is weakened, resulting in IR and eventually inducing NAFLD (Mauvais-Jarvis et al., 2017). Here, INS is linked to metabolic dysfunction-associated steatotic liver disease.